Results

Total Results: 32 records

Showing results for "vte".

21. Anticoagulation for Venous Thromboembolic Events in Patients with Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-venous-thrombosis-anticoagulation/abstract

22. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
    March 13, 2012 - none • Final outcomes: diagnosis of breast cancer, cervical cancer, venous thromboembolic event (VTE … mortality of: • Endometrial cancer • Colorectal cancer Other Harms Incidence and mortality of: • Venous … thromboembolism • Breast cancer • Cervical cancer • Stroke • Myocardial infarction Primary Outcomes … OCs also increase the risk of certain short-term (e.g., venous thromboembolism) and long-term (e.g., … KQ 5: o Final outcomes: diagnosis of breast cancer, cervical cancer, venous thromboembolic event (VTE

23. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - Hand washing + interventions to improve hand washing compliance  Perioperative beta- blockers  VTE

24. Disposition of Comments Report for Comparative Effectiveness Review 128 Oral Mechanical Bowel Preparation for Colorectal Surgery (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_disposition-comments.pdf
    April 30, 2014 - TEP #1 Executive Summary ES-3 Line 48: I vaguely remember discussing venous thromboembolism in our … Are there data indicating that OMBPmight or might not be a risk factor for VTE? … The issue of VTE was discussed (in varying levels of details) in each of the TEP teleconferences we … We decided to include VTE (DVT and PE) outcomes in our review, however the available evidence was limited … prolong hospitalization or slow the rate of recovery post-surgery, and in that way increase the risk of VTE

25. Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - I believe that the authors mean to say “venous” thromboembolism, not arterial. … KQ2: As evidence supports a lower risk of VTE and gall bladder disease with transdermal as compared … is unclear why these studies were not included in the report (pg 111 gallbladder disease; pg 115 VTE … now reads: “Inclusion/exclusion criteria for long term effects (coronary heart disease, stroke, or venous … thromboembolism; gall bladder disease; osteoporotic fractures; or endometrial, breast, colorectal,

26. Grades-Predictive-Values White-Paper-2015 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
    January 01, 2015 - confidence interval) Effect Estimate (confidence interval) Akl et al., 201111 Sympto- matic VTE … ) Effect Estimate (Confidence Interval) Middeldorp et al., 201476 Incidence of recurrent VTE … Status Scale; FEV = forced expiratory volume; RR = relative risk; SMD = standardized mean difference; VTE … = venous thromboembolism Concordance was defined as: aNo change in statistical significance; relative … Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

27. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
    June 07, 2013 - that, ideally, we would have estimates on long-term cause-specific mortality for stroke, MI, PE, and VTE … we have revised this section to clarify which harms (breast and cervical cancer, stroke, MI, PE, VTE

28. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - The study measured recurrence of venous thromboembolism (measurement method not reported), major hemorrhage … A subgroup analysis found that the incidence of venous thromboembolism events in the anti-Xa monitoring … thromboembolism. … Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban … • Subgroup analysis found that the incidence of venous thromboembolism events in the anti-Xa monitoring

29. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
    March 21, 2013 - think that this work adequately evaluates the different progestins and why there may be differences in VTE

30. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
    April 25, 2013 - Whether evidence supports concluding that some patient groups may not be harmed is uncertain— e.g., VTE

31. Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
    April 01, 2021 - used to create report was all done by investigators at EPC Should standard or prolonged- duration VTE

32. Disposition of Comments CER 214 Stroke Prevention in Patients With Atrial Fibrillation (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
    October 30, 2019 - threshold but restrict to studies that performed statistical adjustment or had adequate adjudication of VTE